GlassScriptPhysician profile
Carlos A Sagebien
NPI 1538142666
$36,789.54
in general payments reported to CMS, 2019-2025
12 companies · $9,916 in 2025
The $9,916 reported for 2025 was more than what 87% of Orthopaedic Surgery providers received nationally (typical 2025 total: $569).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $10K · 2020: $412 · 2021: $2,459 · 2022: $473 · 2023: $107 · 2024: $13K · 2025: $9,916.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Consulting Fee: $17K · Travel and Lodging: $4,833 · Food and Beverage: $921.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Consulting Fee | $17,384.99 |
| Travel and Lodging | $4,832.56 |
| Food and Beverage | $921.25 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Kuros Biosciences USA, INC | $22,756.40 | 2024-2025 | Magnetos |
| Smith+Nephew, INC. | $10,255.55 | 2019-2025 | Trigen Intertan |
| Synthes USA Products LLC | $2,340.00 | 2021 | |
| Globus Medical, INC. | $315.62 | 2022 | |
| Biocomposites INC | $275.90 | 2020-2024 | |
| Stryker Corporation | $243.31 | 2020-2024 | Gamma |
| Integra Lifesciences Corporation | $149.34 | 2019 | |
| Avanos Medical | $134.41 | 2019 | |
| Organogenesis INC. | $113.06 | 2020 | |
| Kci USA, INC. | $97.42 | 2020 | |
| Osteocentric Technologies, INC. | $91.71 | 2019 | |
| Depuy Synthes Sales INC. | $16.82 | 2024 | Na |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Carlos Sagebien listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.